PennsylvaniaPennsylvania would screen newborns for Gaucher disease with board approval
Pennsylvania’s health department would include Gaucher disease in newborn screening and follow-up services, with approval from the program’s technical advisory board.
What it does
The state health department would provide newborn screening and follow-up services for Gaucher disease, with the technical advisory board’s approval. The measure would take effect 60 days after enactment.
Argument forScreening could help health care providers identify newborns who need treatment or other services to prevent disability or death.
Argument againstScreening for Gaucher disease could require health care providers to manage more testing and follow-up work for newborns.
More detail
The state health department would include Gaucher disease in newborn screening and follow-up services. The provision covers newborn children in Pennsylvania’s state screening program. The program requires approval from the Newborn Screening and Follow-up Technical Advisory Board. The measure would take effect 60 days after enactment.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Oct 19Re-reported as committedLatest
- Vote recorded Committee vote (Appropriations): Re-Reported as Committed. Result: pass.Upper
- Oct 7Re-referred to AppropriationsMinor
- Oct 7Second considerationMinor
- Oct 6First considerationMinor
- Vote recorded Committee vote (Health & Human Services): Reported as Committed. Result: pass.Upper
- Oct 6Reported as committedMinor
- Aug 10Referred to Health & Human ServicesIntroduced
- Oct 19Re-reported as committedLatest
Healthcare